BioFilm Pharma and BIOASTER announced the signature of a research contract to address the challenge of antibiotic resistance. This collaboration will lead to the deciphering of the mode of action...
BIOASTER announces a collaboration with Exeliom Biosciences, a leading biotech in the developement of innovative microbiome-based therapies, located in Paris and Dijon, France. The aim of the partnership is to...
BIOASTER, the Technology Research Institute (TRI) gives itself the means to develop new partnerships with American foundations invested in the fight against infectious diseases. The BIOASTER Foundation received an “Equivalency...
This video is intended to explain to everyone what the #biofilm is and why it is a key element to improve research, in addition, in the fight against #chronicDiseases and...
Algorithms and microbes: BIOASTER joins other IRTs to accelerate the spread of artificial intelligence in health. With the exception of image analysis, artificial intelligence (AI) in the biomedical field...
Nathalie GARÇON Chief Scientific Officer and Pascale BOISSEL Chief Financial Officer have been respectively named chief executive officer and deputy chief executive officer. Lyon, April 20th, 2015: BIOASTER microbiology technology...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
